Receipt of palivizumab before birth hospitalization discharge among preterm infants in the United States.
about
Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infantsChronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States.Evaluation of hospitalization costs and associated factors among maternity stays involving low-risk and moderate- to high-risk childbirths in the United States.Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants.
P2860
Receipt of palivizumab before birth hospitalization discharge among preterm infants in the United States.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Receipt of palivizumab before ...... infants in the United States.
@en
Receipt of palivizumab before ...... infants in the United States.
@nl
type
label
Receipt of palivizumab before ...... infants in the United States.
@en
Receipt of palivizumab before ...... infants in the United States.
@nl
prefLabel
Receipt of palivizumab before ...... infants in the United States.
@en
Receipt of palivizumab before ...... infants in the United States.
@nl
P2093
P921
P356
P1476
Receipt of palivizumab before ...... m infants in the United States
@en
P2093
Edmund F La Gamma
Frangiscos Sifakis
Rajan Wadhawan
Veena R Kumar
P304
P356
10.1055/S-0034-1543951
P577
2015-04-15T00:00:00Z